Jan Walewski
0000-0003-4247-2674
Maria Sklodowska-Curie Institute - Oncology Center
145 papers found
Refreshing results…
Usefulness of real-time PCR in long-term follow-up of follicular lymphoma patients.
Two autologous transplants in the treatment of patients with Hodgkin's lymphoma: Analysis of prognostic factors and comparison with a single procedure
Serum VEGF and bFGF levels in patients with Hodgkin's lymphoma,Stȩżenia VEGF i bFGF w surowicy krwi chorych na chłoniaka Hodgkina
Serum sIL-2Rα, sTNF RI i sTNF RII concentrations in patients with Hodgkin's lymphoma,Stȩżenia sIL-2Rα, sTNF RI i sTNF RII w surowicy krwi chorych na chłoniaka Hodgkina
The significance of palifermin in reduction of oral mucositis incidence and acute graft-versus-host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant
Results of high-dose therapy followed by autologous HSCT in patients with multiple myeloma. A retrospective multicenter analysis conducted by the Polish Myeloma Group
Pro-inflammatory and inhibitory cytokines in the sera of patients with Hodgkin's lymphoma,Stȩżenia cytokin prozapalnych i inhibitorowych w surowicy krwi chorych na chłoniaka Hodgkina
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group
Unusual Cyclin D1 Positive Marginal Zone Lymphoma of Mediastinum
Unusual IgD+/CD38-Follicular Lymphoma with Leukemic Presentation
Efficacy and safety of bortezomib in treatment of refractory/relapsed multiple myeloma - Polish Myeloma Group experience,Skuteczność i bezpieczeństwo bortezomibu w leczeniu opornego/nawrotowego szpiczaka plazmocytowego - Doświadczenia Polskiej Grupy szpiczakowej
Flow cytometric enumeration of CD34+hematopoietic stem and progenitor cells in leukapheresis product and bone marrow for clinical transplantation: A comparison of three methods
Frequent aberrations of chromosome 8 in aggressive B-cell non-Hodgkin lymphoma
Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519)
Mantle Cell Lymphoma Presenting with Paraproteinemia
Treatment for primary refractory Hodgkin's disease: A comparison of high-dose chemotherapy followed by ASCT with conventional therapy
Autologous haematopoietic stem cell transplantation for the treatment of aggressive non-Hodgkin's lymphoma. The experience of Polish Lymphoma Research Group (PLRG),Autologiczna transplantacja komórek hematopoetycznych w leczeniu agresywnych chłoniaków nieziarniczych Doświadczenie Polskiej Grupy Badawczej Chłoniaków (PLRG)
An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study
High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin’s disease. Retrospective study of the Polish Lymphoma Research Group
Missing publications? Search for publications with a matching author name.